Why the study?
Does nifedipine GITS prevent cardiovascular events in high-risk hypertensive patients compared to co-amilozide?
Does nifedipine GITS prevent cardiovascular events in high-risk hypertensive patients compared to co-amilozide?
Nifedipine GITS is as effective as co-amilozide in preventing clinical cardiovascular events in high-risk hypertensive patients, with additional benefits on surrogate markers of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Nifedipine GITS may provide comparable event prevention with surrogate advantages in high-risk hypertension; leaves open prospective outcome confirmation.
Luís M. Ruilope (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: